glutathione disulfide has been researched along with Adenocarcinoma, Clear Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiko, K; Amano, Y; Baba, T; Hamanishi, J; Kharma, B; Konishi, I; Mandai, M; Matsumura, N; Yamaguchi, K; Yoshioka, Y | 1 |
1 other study(ies) available for glutathione disulfide and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.
Topics: Adenocarcinoma, Clear Cell; Amino Acid Transport Systems, Basic; Amino Acid Transport Systems, Neutral; Antineoplastic Agents; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Disulfide; Glycolysis; Hepatocyte Nuclear Factor 1-beta; Humans; Metabolome; Metabolomics; Ovarian Neoplasms; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2015 |